(Hypertension. 1995;26:524-530.)
© 1995 American Heart Association, Inc.
Articles |
Short- and Long-term Effects of Antihypertensive Drugs on Arterial Reflections, Compliance, and Impedance
From the Veterans General Hospital, Taichung (C.-T.T.) and Taipei (C.-H.C., M.-S.C.), Taiwan, and Johns Hopkins Hospital, Baltimore, Md (F.C.P.Y.).
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Abstract This article reviews our work on the effects of different classes of antihypertensive agents on the hemodynamic alterations in essential human hypertension. Short-term studies were done during cardiac catheterization in young normotensive subjects (mean age, 33 years; range, 19 to 40) and several different age-matched (range, 25 to 53 years) groups of patients with essential hypertension. Aortic impedance, resistance, wave reflections, and compliance were calculated from high-fidelity recordings of ascending aortic pressure and flow signals during baseline and after nitroprusside, propranolol followed by phentolamine, phentolamine, captopril, and nifedipine, respectively, at doses sufficient to normalize blood pressure in each hypertensive group. Propranolol exacerbated all the hemodynamic parameters; these effects were only partially overcome by phentolamine. Among the other agents only phentolamine did not completely normalize compliance, and only captopril did not completely normalize wave reflections. The long-term study was a randomized, double-blind comparison of fosinopril and atenolol in 79 normotensive subjects and 79 essential hypertensive patients. Baseline 24-hour ambulatory blood pressures and carotid artery tonometry to index wave reflections were performed in all subjects and in hypertensive patients after 8 weeks of therapy. Both fosinopril and atenolol normalized blood pressure and lowered the elevated augmentation index, but fosinopril had a significantly larger effect than atenolol. Both short- and long-term ß-blockade did not have as beneficial an effect as the other agents. Thus, the differing hemodynamic effects of the various classes of antihypertensive agents might be a consideration in the choice of therapy.
Key Words: hypertension, essential • vasodilator agents • captopril • nitroprusside • receptors, adrenergic, beta • receptors, adrenergic, alpha • calcium antagonist
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Compared with age-matched normotensive control subjects, humans with essential hypertension have distinctly altered hemodynamics, including increased arterial resistance, wave reflections, and impedance and decreased compliance.1 2 3 4 5 Dysfunction of several systems has been identified in essential hypertension, including alterations in autonomic nervous system activity,6 7 8 9 10 abnormal levels of circulating and tissue angiotensin,11 12 13 14 15 16 altered vascular endothelial function,17 18 and abnormal calcium handling by vascular smooth muscle cells.19 20 21 22 23 Consequently, antihypertensive agents specifically aimed at one or more of these systems have been developed. Since the various classes of antihypertensive agents have different mechanisms of action on the arterial system, one might expect them to affect the altered hemodynamics differently after both short- and long-term administration.
Detailed characterization of many aspects of hemodynamic function, such as arterial impedance and wave reflection, currently requires invasive measurement of high-fidelity pressures and flows during cardiac catheterization.24 25 26 27 28 29 30 Consequently, such measurements are restricted to a few selected patients and are suitable for examination of only the short-term effects of drugs. Some recently described noninvasive techniques such as Doppler ultrasound31 32 and arterial applanation tonometry33 34 35 are now able to provide some corroborating measurements of a few aspects of hemodynamics, such as regional compliance and wave reflection, respectively. Hence, these techniques allow for the examination of long-term effects of antihypertensive agents.
Using invasive techniques we examined the short-term
hemodynamic effects of several different classes of
antihypertensive agents (smooth muscle dilator, ß-blocker,
-blocker, angiotensin-converting enzyme [ACE]
inhibitor, and calcium channel blocker) in several
different groups of patients with essential hypertension. We also used
noninvasive techniques in a randomized double-blind comparison of a
ß-blocker and ACE inhibitor. This review summarizes our
results.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Short-term Studies
Patients and Study Protocol
Normotensive data were obtained from patients (mean age, 32.6 years; range, 19 to 40) undergoing diagnostic cardiac catheterization for other reasons (usually electrophysiological studies). Five different age-matched (mean age, 34.1 years; range, 25 to 53) groups of hypertensive patients were studied. During multiple clinic visits and after hospital bed rest, all these hypertensive patients consistently had sphygmomanometric blood pressure (BP) readings greater than 140/90 mm Hg. Secondary causes of hypertension were ruled out in every patient. Those entered into the study either had never been treated for hypertension or had their antihypertensive medications discontinued for at least 2 weeks before study. None of the normotensive subjects or hypertensive patients had coronary artery disease, valvular heart disease, or physical findings of peripheral or carotid artery disease. All patients gave informed consent for the study according to institutional guidelines. A two-dimensional echocardiogram for assessment of aortic root diameter was performed in every patient. Since we have previously shown that aortic root cross-sectional areas did not vary by more than 0.2 cm2 when BP values were lowered over the same range as in these patients,1 we used this initial estimate of aortic root area to convert the flow velocity (see below) to volume flow.
All patients were premedicated with chlorpheniramine maleate (5 mg IM).
At the time of catheterization a catheter (model VPC
673-D or SVPC 684-D, Millar Instruments) containing a
micromanometer and electromagnetic flow velocity
sensor was advanced into the aortic root through a femoral artery
sheath. Baseline pressures, flows, and
electrocardiograms were recorded on analog tape for
later off-line analysis. For each group a dose of the selected
antihypertensive agent then was administered according to the following
procedures: (1) For the nitroprusside group1
intravenous nitroprusside was begun at a dose of 0.25
mcg/kg per minute and doubled every 3 minutes until BP fell into the
normal range. (2) For the adrenergic blockade groups36
intravenous propranolol was given at a rate of
1 mg/min until a total dose of 0.15 mg/kg was administered.
Recordings were made several minutes after completion of the
infusion. Combined - and ß-blockade then was produced by
administration of intravenous phentolamine
beginning at a rate of 1 mg/min. The dose was increased by 1 mg/min
every 3 minutes until both systolic and diastolic pressures
fell into the normal range. Recordings were made for 3 to 5
minutes on completion of the infusion. (3) For the -blockade only
group (unpublished data) intravenous phentolamine
was given according to the same protocol as above. (4) For the
captopril group37 2 mg was first given
intravenously over 1 minute, and recordings were
made after 10 minutes. If either systolic or diastolic
pressure was still elevated, another 4 mg was given. If after 10
minutes pressures were still elevated, 8 mg was given. The average dose
used was 11 mg (range, 6 to 14 mg). (5) For the nifedipine
group38 10 or 20 mg of sublingual nifedipine
was given depending on whether the diastolic pressure was
less or greater than 105 mm Hg, respectively. After 15 minutes if
either systolic or diastolic pressure was still elevated,
another 10 mg was given sublingually, and recordings were made
after another 15 minutes. The average maximum dose was 24.2 mg (range,
10 to 30 mg).
Data Analysis
The calibration and data analysis methods have been
reported in detail previously.1 In brief, the pressure and
flow signals were resolved into their Fourier harmonics. The impedance
modulus and phase angle for each harmonic were calculated as the ratio
of the pressure and flow modulus and the flow minus the pressure angle,
respectively. The pressure signal was then decomposed into its forward
(Pf) and backward (Pb)
components,39 from which an index of wave reflection
(Pb/Pf) was calculated. For comparison
with the long-term studies, another index of the effect of wave
reflections, the augmentation index (AI), was calculated from the
ascending aortic pressure signals with the use of previously described
definitions.26 40 41 42 Finally, an estimate of
arterial compliance was obtained (assuming a three-element
Windkessel model for the arterial system) with the use of
the pressure-area method.30 43 The results reported herein
are for the compliance extrapolated to zero pressure (C0).
Because this method explicitly accounts for the pressure dependence of
compliance, calculations of compliance at the prevailing levels of
systolic, diastolic, and mean pressures can be obtained
simply by multiplying C0 by the parameter
ebP, where b is a constant (taken here to be
-0.001) and P is the pressure. The data reported here
represent the averages from a minimum of 6 (usually closer to
15) beats.
Statistical comparisons were performed using unpaired t tests and repeated measures ANOVA with the Bonferroni correction for multiple comparisons as appropriate. Statistical significance was assumed at a value of P=.05.
Long-term Study
Study Subjects
From a mass public health screening of residents older than 30
years in a region of Taiwan and on Quemoy Island, we identified 79
normotensive subjects (BP <140/90 mm Hg) and 79 hypertensive
patients. From a complete history, physical examination, and routine
blood tests, individuals with secondary hypertension, malignant
hypertension, unstable angina, myocardial infarction within the
preceding 6 months, liver or renal function abnormalities, or
contraindications for ß-blockers or ACE inhibitors were
excluded. After giving informed consent the hypertensive patients
stopped previous antihypertensive drugs and received placebos for 2
weeks. Only those with an average of the three sitting
diastolic BP values between 95 and 110 mm Hg after 2 weeks
of placebo treatment were entered into the study. The study was a
double-blind design with patients randomly assigned to receive 10 mg
fosinopril daily (41 patients) or 50 mg atenolol daily (38 patients).
The dosage was doubled if the average sitting diastolic BP
was above 90 mm Hg after 2 weeks of active treatment.
Dihydrochlorothiazide (25 mg daily) was then added
if the averaged diastolic BP was still above 90 mm Hg
after 4 weeks of active treatment. This was required in 29 of the 41
fosinopril patients and 23 of the 38 atenolol patients. The medication
was continued for another 4 weeks. Ambulatory BP, carotid tonometry,
and echocardiography (see below) were performed at
the first visit and after 8 weeks of treatment. The data reported are
for the entire hypertensive group as well as for the subgroup that did
not receive diuretic therapy. All of these same measurements
were made in the normotensive group at the time of the visit to the
public health clinic.
Ambulatory BP
To obtain a more representative assessment of BP
profiles than available from single clinic visits, we recorded
baseline 24-hour ambulatory BP using a SpaceLabs 90207
recorder44 in all subjects as well as 24-hour BP after
completion of drug treatment in the hypertensive patients. The
recorder was programmed to deflate in steps of 4 mm Hg at
20-minute intervals during the daytime (7 AM to 10
PM) and at 60-minute intervals during the nighttime (11
PM to 6 AM). Usually, 50 to 60 readings
throughout 24 hours could be obtained in most patients. Patients were
advised to work as usual during monitoring but to minimize movement of
the arm in which BP was being measured. The 24-hour readings were not
edited manually, but the software from the manufacturer stipulates that
records with less than 80% successful measurements be excluded.
None of our subjects were excluded from analysis for failing to
meet this criterion. The mean 24-hour systolic BP,
diastolic BP, and heart rate, as well as mean hourly BP and
heart rate, were obtained directly from the report generated by a
computer software package after the data were retrieved from the
recorder through an interface.
Carotid Tonometry
The arterial pressure wave contour with the subject
in the supine position was obtained noninvasively from the right common
carotid artery with a hand-held 7-mm-diameter pencil-type probe
incorporating a micromanometer (Millar
Instruments).33 34 35 The carotid waveform was digitized at a
rate of 250 Hz and stored on an IBM-compatible microcomputer for
off-line analysis. The digitized signals were analyzed
with the use of custom software written in our laboratory. Two to 10
consecutive beats were signal averaged. Premature beats and beats
immediately after premature beats were excluded. From this
signal-averaged beat we calculated the AI as previously
described.26 40 41 42 The interobserver variability of the
carotid AI has been determined from another 62 patients. The
observations of the two observers were consistent and highly
correlated with a regression equation of
y=1.06x+0.45 (SEE=0.04, R=.964,
P<.001). The intraclass correlation coefficient was .95,
with a 95% confidence interval of .88 to .98. There was a significant
but small mean difference between the two independent observers'
values of -0.15 (=.002). The long-term AI data reported herein
are those of one observer (C.-H.C.).
Statistical Analysis
All variables are expressed as mean±SD. The within-groups
and between-groups comparisons of BP and AI were performed using
two-way ANOVA. An identical analysis was performed for the
subgroup of subjects who did not receive diuretic therapy.
Statistical significance was considered to be at a value of
P=.05 although all probability values less than .10 are
listed.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Short-term Studies
The results for the short-term studies are summarized in Figs 1 through 7, which show the heart rate, BP, arterial resistance, first harmonic of the impedance modulus, wave reflection index, aortic AI, and compliance at extrapolated zero pressure responses, respectively, for the normotensive subjects and each group of hypertensive patients. Each of the drugs normalized BP. Each drug with the exception of propranolol reduced resistance and the impedance modulus to normal. This deleterious effect of ß-blockade could be only partially overcome by
-blockade. ß-Blockade had a similar deleterious effect
on both the wave reflection index and AI as well as on compliance. Only
nitroprusside and the calcium channel antagonist were able
to completely normalize all the hemodynamic
parameters. Phentolamine did not completely
normalize compliance, and captopril did not completely normalize wave
reflections.
|
|
|
|
|
|
|
Long-term Study
The results of the long-term study are summarized in Figs 8 through 10, which
illustrate 24-hour heart rate and BP and the carotid AI responses,
respectively. Results for individuals taking the two drugs along with
the diuretic as well as those for the subgroup taking only the
drugs are shown. In general, the results for the subgroups and the
whole groups were consonant. As expected, atenolol decreased heart rate
compared with normotensive control subjects and the fosinopril group.
Both atenolol and fosinopril decreased peripheral BP to
normal and by the same extent. Although both drugs lowered the carotid
AI, the response to atenolol was significantly smaller than that to
fosinopril, resulting in a trend toward a persistently higher AI
compared with the normotensive subjects. Results observed in those in
whom the antihypertensive agent was used as monotherapy were similar to
results in those in whom the diuretic had been added. In these
subgroups the AI resulting after atenolol treatment was significantly
higher than in the normotensive subjects. This more beneficial action
of the ACE inhibitor than the ß-blocker on wave
reflection is similar but not identical to the short-term actions of
these types of drugs described above in which the ß-blocker actually
exacerbated wave reflections rather than decreasing them to normal
levels.
|
|
|
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
The main findings of this series of studies are the following: (1) There are distinct hemodynamic alterations associated with essential hypertension whose details can be elucidated with invasive measurements. (2) The various classes of antihypertensive agents affect these hemodynamic alterations differently; only a nonspecific smooth muscle vasodilator (nitroprusside) and a calcium antagonist (nifedipine) completely normalized all the hemodynamic alterations after short-term administration. ß-Blockade actually appeared to be deleterious. (3) The more beneficial action of an ACE inhibitor compared with a ß-blocker appeared to be maintained during 8 weeks of administration whether or not a diuretic was added. (4) New noninvasive techniques such as applanation tonometry might be useful for assessing the effects of, for instance, wave reflections.
The similarity of the baseline alterations among the several different groups of hypertensive patients, which were studied over a period of several years, helps confirm that these distinct alterations are indeed a hallmark of this young, essential hypertensive population. Some of these findings have been reported in previous studies,3 4 45 46 but to our knowledge this combined group comprises the largest and most homogeneous group of essential hypertensive patients in which such detailed measurements have been made.
For many reasons it is perhaps not surprising to find a disparity of action of these drugs. First, the predominant modes of actions of these various antihypertensive agents differ. Second, the actions of each drug may not necessarily be limited to a single system.14 47 48 49 Third, a particular class of drug, for example, a calcium channel antagonist, may have variable actions in the arterial tree.50 There is some evidence that the hemodynamic parameters we measured may represent predominant contributions from different regions of the arterial system (eg, compliance from the proximal aorta,51 wave reflections from near the renal and aortic bifurcations,52 53 and resistance from the periphery54 ). Our long-term data also indicate that the different beneficial effects on reducing central wave reflections of ß-blockade and ACE inhibition were not manifested by any difference between the drugs in their effects on peripheral BP. Similar observations with other vasodilators have been reported.55 56 57 58 Clearly, more detailed regional measurements are needed to delineate the specific regional effects of the various drug classes.
The parallelism between the results of our short- and long-term observations on the effects of ß-blockade and calcium antagonism on wave reflections (ß-blockade was deleterious in the short term and less beneficial in the long term) is encouraging. These results suggest that at least under some conditions long-term effects might be predictable from short-term responses. If these results can be generalized, the data suggest that a calcium channel blocker might be the optimal drug for normalizing hemodynamics; this is supported by studies showing a beneficial effect of long-term calcium channel blockade on vessel compliance and other hemodynamic parameters.57 58 59 60 61 62 The beneficial effects of calcium antagonism are consistent with the observation that nitroprusside completely normalized hemodynamics.1 63 Since both of these agents act directly at a common denominator, namely, the vascular smooth muscle, the results suggest that at least at this young age the hemodynamic alterations are related to reversible, excessive levels of smooth muscle tone in the arterial system; however, the specific mechanisms still need to be resolved.
One reason for the deleterious action of the ß-blocker may be that it
unmasks a degree of -adrenergically mediated vasoconstriction
because some of its deleterious effects are reversed when an
-blocker is added to ß-blockade. Similar effects have been
observed in other studies.45 64 65 How much this
short-term effect is ameliorated over time is unclear, but our data
suggest that not all of it is. Other possible reasons relate to the
heart rate–lowering effect of ß-blockers. This may be
deleterious from two standpoints. First, because of the steep fall of
the impedance modulus curve in the low-frequency range, lowering heart
rate, that is, the fundamental frequency, causes the heart and
arterial system to interact less efficiently, in that more
energy is expended in producing pulsations. Second, slowing heart rate
provides an opportunity for the reflected wave (if the pulse wave
velocity is unchanged) to appear in late systole rather than in
diastole, thereby increasing the AI.
Both the short- and long-term ACE inhibitor results show
only a partial normalization of wave reflections. Although this could
be due to the fact that abnormalities of this system are not the sole
or predominant mechanism for essential hypertension, there is another
possibility. The fact that both indexes were only partially normalized
suggests that there may be an upper limit of potential
hemodynamic benefit obtainable from this type of agent.
Likewise, -adrenergically mediated tone is probably not the complete
explanation for the hemodynamic alterations because
arterial compliance was not completely normalized after
-blockade. In fact, examination of compliance at other pressures
clearly indicated that -blockade by itself or with ß-blockade did
not normalize compliance (data not shown).
Some limitations to our results deserve comment. First, all of our short-term studies were performed after premedication with chlorpheniramine. How and whether this drug affects hemodynamic responses differently in normotensive subjects or hypertensive patients is not known but deserves examination. Second, even though our long-term data indicate that the combination of an ACE inhibitor or ß-blocker with a thiazide diuretic results in the same hemodynamic responses as those drugs without the added diuretic, these results do not directly address the issue of the direct effect of a diuretic alone on the hemodynamic responses such as aortic impedance, wave reflections, and compliance. Since thiazide diuretics may have some effect on the renin-angiotensin system, it would be useful to have such information. To our knowledge, this is not available.
Although noninvasive techniques probably will never be able to describe hemodynamics in as detailed a fashion as invasive techniques, they may play an increasingly important role for the examination of certain aspects of function such as wave reflection. For example, in recent years applanation tonometry has received wide attention, and several studies seem to suggest that it is a reasonably reliable method for noninvasively indexing the results of wave reflections.33 34 35 Even though the AI is an indirect and the wave reflection index is a direct measure of the extent of wave reflections, both responded in the same manner to the various drugs. This indicates that the AI, whether recorded invasively from the aortic pressure trace or noninvasively from the carotid artery, is a reasonably accurate indicator of the amount of reflection in the arterial system. There are still clear limitations to this technique, such as the problematic issue of absolutely quantifying BP, that must be kept in mind. As other techniques for noninvasive estimation of central aortic pressures, flows, and anatomy become available,57 66 the goal of being able to noninvasively yet adequately assess the arterial system for purposes such as those described here nears reality.
|
Acknowledgments |
|---|
This work was supported in part by grant DOH 84-HR-204 from the Department of Health, the Executive Yuan of the Republic of China.
|
Footnotes |
|---|
Reprint requests to Chih-Tai Ting, Division of Cardiology, Taichung Veterans General Hospital, 160 Section 3, Chung-Kang Rd, Taichung, Taiwan.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Ting CT, Brin KP, Lin SJ, Wang SP, Chang MS, Chiang BN, Yin FCP. Arterial hemodynamics in human hypertension. J Clin Invest. 1986;78:1462-1471.
2.
Liu Z, Ting CT, Zhu S, Yin FCP. Aortic
compliance in human hypertension.
Hypertension. 1989;14:129-136.
3. Merillon JP, Fontenier GJ, Lerallut JF, Jaffrin MY, Motte GA, Genain CP, Gourgon RR. Aortic input impedance in normal man and arterial hypertension: its modification during changes in aortic pressure. Cardiovasc Res. 1982;16:646-656. [Medline] [Order article via Infotrieve]
4.
Nichols WW, O'Rourke MF, Avolio AP, Yaginuma T,
Pepine CJ, Conti CR. Ventricular/vascular
interaction in patients with mild systemic hypertension and normal
peripheral resistance.
Circulation. 1986;74:455-462.
5. Simon AC, Safar ME, Levenson JA, London GM, Levy BI, Chau NP. An evaluation of large arteries compliance in man. Am J Physiol. 1979;237:H550-H554.
6. Philipp T, Distler A, Cordes U. Sympathetic nervous system and blood-pressure control in essential hypertension. Lancet. 1978;2:959-963. [Medline] [Order article via Infotrieve]
7. Buhler FR, Amann FW, Bolli P, Hulthen L, Kiowski W, Landmann R, Burgisser E. Elevated adrenaline and increased alpha-adrenoceptor mediated vasoconstriction in essential hypertension. J Cardiovasc Pharmacol. 1982;4:S134-S138.
8. Kiowski W, van Brummelen P, Buhler FR. Plasma noradrenaline correlates with alpha-adrenoreceptor mediated vasoconstriction and blood pressure in patients with essential hypertension. Clin Sci. 1979;57:177-180.
9. Jie K, Van Brummelen P, Vermey P, Timmermans PBWM, Van Zwieten PA. Alpha 1- and alpha 2-adrenoceptor mediated vasoconstriction in the forearm of normotensive and hypertensive subjects. J Cardiovasc Pharmacol. 1986;8:190-196. [Medline] [Order article via Infotrieve]
10. Van Zwieten PA, Timmermans PBWM, Van Brummelen P. Role of alpha adrenoceptors in hypertension and in antihypertensive drug treatment. Am J Med. 1984;77(suppl 4a):17-25.
11.
Dzau VJ, Safar ME. Large conduit arteries in
hypertension: role of the vascular renin-angiotensin
system. Circulation. 1988;77:947-954.
12.
Lilly LS, Pratt RE, Alexander RW, Larson DM, Ellison
KE, Gimbrone MA Jr, Dzau VJ. Renin expression by vascular
endothelial cells in culture.
Circ Res. 1985;57:312-318.
13.
Kifor I, Dzau VJ. Endothelial
renin-angiotensin pathway: evidence for intracellular
synthesis and secretion of angiotensins.
Circ Res. 1987;60:422-428.
14.
Berecek KH, Kirk KA, Nagahama S, Oparil S.
Sympathetic function in spontaneously hypertensive rats after chronic
administration of captopril. Am J Physiol. 1987;252:H796-H806.
15. Williams GH. Converting-enzyme inhibitors in the treatment of hypertension. N Engl J Med. 1988;319:1517-1525. [Medline] [Order article via Infotrieve]
16. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, Corvol P. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992;71:169-180. [Medline] [Order article via Infotrieve]
17.
Luscher TF, Seo BG, Buhler FR. Potential role of
endothelin in hypertension. Hypertension. 1993;21:752-757.
18.
Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA.
Role of endothelium-derived nitric oxide in the
abnormal endothelium-dependent vascular relaxation of
patients with essential hypertension.
Circulation. 1993;87:1468-1474.
19. Cohn JN. Calcium, vascular smooth muscle, and calcium entry blockers in hypertension. Ann Intern Med. 1983;98:806-809.
20. Robinson BF, Collier JG, Dobbs RJ. Comparative dilator effect of verapamil and sodium nitroprusside in forearm arterial bed and dorsal hand veins in man: functional differences between vascular smooth muscle in arterioles and veins. Cardiovasc Res. 1979;13:16-21. [Medline] [Order article via Infotrieve]
21. Fleckenstein A, Frey M, Fleckenstein-Grun G. Antihypertensive and arterial anticalcinotic effects of calcium antagonists. Am J Cardiol. 1986;57:1D-10D. [Medline] [Order article via Infotrieve]
22. Fleckenstein-Grun G, Frey M, Thimm F, Hofgartner W, Fleckenstein A. Calcium overload: an important cellular mechanism in hypertension and arteriosclerosis. Drugs. 1992;44(suppl 1):23-30.
23. Hulthen UL, Bolli P, Amann FW, Kiowski W, Buhler FR. Enhanced vasodilatation in essential hypertension by calcium channel blockade with verapamil. Hypertension. 1982;4(suppl II):II-26-II-31.
24. Milnor WR. Hemodynamics. Baltimore, Md: Williams & Wilkins; 1982:167-224.
25.
Milnor WR. Arterial impedance
as ventricular afterload. Circ
Res. 1975;36:565-570.
26.
Murgo JP, Westerhof N, Giolma JP, Altobelli SA.
Manipulation of ascending aortic pressure and flow wave reflections
with the Valsalva maneuver: relationship to input impedance.
Circulation. 1981;63:122-132.
27.
Murgo JP, Westerhof N, Giolma JP, Altobelli SA.
Aortic input impedance in normal man: relationship to pressure
waveforms. Circulation. 1980;62:105-116.
28. Westerhof N, Van Den Bos GC, Laxminarayan S. Arterial reflection. In: Bauer RD, Buse R, eds. The Arterial System. Berlin, FRG: Springer-Verlag; 1978:48-62.
29. Westerhof N, Sipkema P, Elzinga G, Murgo JP, Giolma JP. Arterial impedance. In: Hwang HC, Gross DR, Patel DJ, eds. Quantitative Cardiovascular Studies: Clinical and Research Applications of Engineering Principles. Baltimore, Md: University Park Press; 1979:111-150.
30.
Liu Z, Brin KP, Yin FCP. Estimation of total
arterial compliance: an improved method and evaluation of
current methods. Am J Physiol. 1986;251:H588-H600.
31.
Reneman RS, Van Merode T, Hick P, Hoeks APG.
Flow velocity patterns in and distensibility of the carotid artery bulb
in subjects of various ages. Circulation. 1985;71:500-509.
32. Van Merode T, Van Bortel L, Smeets FAM, Bohm R, Mooij J, Rahn KH, Reneman RS. The effect of verapamil on carotid artery distensibility and cross-sectional compliance in hypertensive patients. J Cardiovasc Pharmacol. 1990;15:109-113. [Medline] [Order article via Infotrieve]
33.
Kelly R, Hayward C, Avolio A, O'Rourke M.
Noninvasive determination of age-related changes in the human
arterial pulse. Circulation. 1989;80:1652-1659.
34. Kelly R, Karamanoglu M, Gibbs H, Avolio A, O'Rourke M. Noninvasive carotid pressure wave registration as an indicator of ascending aortic pressure. J Vasc Med Biol. 1989;1:241-247.
35. Kelly R, Hayward C, Ganis J, Daley J, Avolio A, O'Rourke M. Noninvasive registration of the arterial pressure pulse waveform using high-fidelity applanation tonometry. J Vasc Med Biol. 1989;1:142-149.
36.
Ting CT, Chou CY, Chang MS, Wang SP, Chiang BN, Yin
FCP. Arterial hemodynamics in human
hypertension: effects of adrenergic blockade.
Circulation. 1991;84:1049-1057.
37.
Ting CT, Yang TM, Chen JW, Chang MS, Yin FCP.
Arterial hemodynamics in human
hypertension: effects of angiotensin converting enzyme
inhibition. Hypertension. 1993;22:839-846.
38.
Ting CT, Chen JW, Chang MS, Yin FCP.
Arterial hemodynamics in human
hypertension: effects of the calcium-channel antagonist
nifedipine. Hypertension. 1995;25:1326-1332.
39. Westerhof N, Sipkema P, Van Den Bos GC, Elzinga G. Forward and backward waves in the arterial system. Cardiovasc Res. 1972;6:648-656. [Medline] [Order article via Infotrieve]
40. Takazawa K. A clinical study of the second component of left ventricular systolic pressure. J Tokyo Med Coll. 1987;45:256-270.
41. Fujii M, Yaginuma T, Takazawa K, Toshitaka N, Komatsu H, Katsuki T, Watabiki H, Kawada Y, Hosoda S. Non-invasive detection for wave reflection in the arterial system by using carotid pulse wave, and its clinical application. J Jpn Coll Angiol. 1989;29:545-551.
42. Miyashita H, Ikeda U, Tsuruya Y, Sekiguchi H, Shimada K, Yaginuma T. Noninvasive evaluation of the influence of aortic wave reflection on left ventricular ejection during auxotonic contraction. Heart Vessels. 1994;9:30-39. [Medline] [Order article via Infotrieve]
43. Yin FCP, Ting CT. Compliance changes in physiological and pathological states. J Hypertens. 1992;10(suppl 6):S31-S33.
44. O'Brien E, Mee F, Atkins N, O'Malley K. Accuracy of the SpaceLabs 90207 determined by the British Hypertension Society Protocol. J Hypertens. 1991;9:573-574. [Medline] [Order article via Infotrieve]
45. Lund-Johansen P. Hemodynamic alterations in hypertension: spontaneous changes and effects of drug therapy: a review. Acta Med Scand. 1977;603(suppl):1-14.
46.
Nichols WW, Conti CR, Walker WE, Milnor WR.
Input impedance of the systemic circulation in man.
Circ Res. 1977;40:451-458.
47. Zimmerman BG. Adrenergic facilitation by angiotensin: does it serve a physiological function? Clin Sci. 1981;60:343-348. [Medline] [Order article via Infotrieve]
48. Swartz SL, Williams GH. Angiotensin-converting enzyme inhibition and prostaglandins. Am J Cardiol. 1982;49:1405-1409. [Medline] [Order article via Infotrieve]
49.
Carretero OA, Miyazaki S, Scicli AG. Role of
kinins in the acute antihypertensive effect of the converting enzyme
inhibitor captopril.
Hypertension. 1981;3:18-22.
50. Bevan JA, Bevan RD, Hwa JJ, Owen MP, Tayo FM. Calcium regulation in vascular smooth muscle: is there a pattern to its variability within the arterial tree? J Cardiovasc Pharmacol. 1986;8(suppl 8):S71-S75.
51. Campbell KB, Ringo JA, Klavano PA, Robinette JD, Alexander JE. Aortic bulb-aortic orifice hemodynamics in left ventricle-systemic arterial interaction. Am J Physiol. 1985;248:H132-H142.
52.
Latham RD, Westerhof N, Sipkema P, Rubal BJ, Reuderink
P, Murgo JP. Regional wave travel and reflections along the
human aorta: a study with six simultaneous micromanometric
pressures. Circulation. 1985;72:1257-1269.
53.
Ting CT, Chang MS, Wang SP, Chiang BN, Yin FCP.
Regional pulse wave velocities in hypertensive and normotensive
humans. Cardiovasc Res. 1990;24:865-872.
54.
Bohlen HG. Localization of vascular resistance
changes during hypertension. Hypertension. 1986;8:181-183.
55.
Kelly RP, Gibbs HH, O'Rourke MF, Daley JE, Mang K,
Morgan JJ, Avolio AP. Nitroglycerin has more
favourable effects on left ventricular afterload than
apparent from measurement of pressure in a peripheral
artery. Eur Heart J. 1990;11:138-144.
56.
Kelly R, Daley J, Avolio A, O'Rourke M.
Arterial dilation and reduced wave reflection:
benefit of dilevalol in hypertension.
Hypertension. 1989;14:14-21.
57.
Cholley BP, Shroff SG, Sandelski J, Korcarz C, Balasia
BA, Jain S, Berger DS, Murphy MB, Marcus RH, Lang RM.
Differential effects of chronic oral antihypertensive therapies on
systemic arterial circulation and ventricular
energetics in African-American patients.
Circulation. 1995;91:1052-1062.
58. Guerin AP, Pannier BM, Marchais SJ, Metivier F, Safar M, Lundon GM. Effects of antihypertensive agents on carotid pulse contour in humans. J Hum Hypertens. 1992;6(suppl 2):S37-S40.
59. Levenson J, Simon AC, Bouthier J, Maarek BC, Safar ME. The effect of acute and chronic nicardipine therapy on forearm arterial haemodynamics in essential hypertension. Br J Clin Pharmacol. 1984;20:107S-113S.
60. Bonaduce D, Ferrara N, Petretta M, Romano E, Postiglione M, Rengo F, Condorelli M. Hemodynamic study of nifedipine administration in hypertensive patients. Am Heart J. 1983;105:865-867. [Medline] [Order article via Infotrieve]
61. Safar ME, London GM, Safavian A, Laurent S, Pannier B. Changes in arterial distensibility produced by converting enzyme inhibitors in hypertensive humans. Clin Exp Hypertens A. 1987;9:289-295. [Medline] [Order article via Infotrieve]
62. Van Merode T, Van Bortel LM, Smeets FA, Mooij JM, Bohm RO, Rahn KH, Reneman RS. Verapamil and nebivolol improve carotid artery distensibility in hypertensive patients. J Hypertens. 1989;7(suppl 6):S262-S263.
63. Pepine CJ, Nichols WW, Curry RC Jr, Conti CR. Aortic input impedance during nitroprusside infusion. J Clin Invest. 1979;64:643-654.
64. Hansson L, Zweifler AJ, Julius S, Hunyor SN. Hemodynamic effects of acute and prolonged beta-adrenergic blockade in essential hypertension. Acta Med Scand. 1974;196:27-34. [Medline] [Order article via Infotrieve]
65.
Ulrych M, Frohlich ED, Dustan HP, Page IH.
Immediate hemodynamic effects of beta-adrenergic
blockade with propranolol in normotensive and hypertensive
man. Circulation. 1968;37:411-416.
66.
Sharir T, Marmor A, Ting CT, Chen JW, Liu CP, Chang MS,
Yin FCP, Kass DA. Validation of a method for noninvasive
measurement of central arterial pressure.
Hypertension. 1993;21:74-82.
This article has been cited by other articles:
 |
|
 |
|
  B. Williams, P. S. Lacy, and for the CAFE and the ASCOT (Anglo-Scandinavian Car Impact of heart rate on central aortic pressures and hemodynamics: analysis from the CAFE (Conduit Artery Function Evaluation) Study: CAFE-Heart Rate. J. Am. Coll. Cardiol., August 18, 2009; 54(8): 705 - 713. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. O'Rourke and C. S. Hayward The pulse of cardiology: quo vadis? J. Am. Coll. Cardiol., August 18, 2009; 54(8): 714 - 717. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Kaihura, M. D. Savvidou, J. M. Anderson, C. M. McEniery, and K. H. Nicolaides Maternal arterial stiffness in pregnancies affected by preeclampsia Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H759 - H764. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-H. Lee, S. Choi, J.-H. Jung, and N. Lee Effects of Atrial Fibrillation on Arterial Stiffness in Patients With Hypertension Angiology, August 1, 2008; 59(4): 459 - 463. [Abstract] [PDF]
|
|
|
|
 |
|
 M. P Schneider, C. Delles, A. U Klingbeil, M. Ludwig, R. E Kolloch, M. Krekler, K. O Stumpe, and R. E Schmieder Effect of angiotensin receptor blockade on central haemodynamics in essential hypertension: results of a randomised trial Journal of Renin-Angiotensin-Aldosterone System, March 1, 2008; 9(1): 49 - 56. [Abstract] [PDF]
|
|
|
|
|
|
M. F. O'Rourke and J. Hashimoto Mechanical Factors in Arterial Aging: A Clinical Perspective J. Am. Coll. Cardiol., July 3, 2007; 50(1): 1 - 13. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Safar Mechanism(s) of Systolic Blood Pressure Reduction and Drug Therapy in Hypertension Hypertension, July 1, 2007; 50(1): 167 - 171. [Full Text] [PDF]
|
|
|
|
|
|
G. F. Mitchell, M. E. Dunlap, W. Warnica, A. Ducharme, J. M. O. Arnold, J.-C. Tardif, S. D. Solomon, M. J. Domanski, K. A. Jablonski, M. M. Rice, et al. Long-Term Trandolapril Treatment Is Associated With Reduced Aortic Stiffness: The Prevention of Events With Angiotensin-Converting Enzyme Inhibition Hemodynamic Substudy Hypertension, June 1, 2007; 49(6): 1271 - 1277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Laurent, J. Cockcroft, L. Van Bortel, P. Boutouyrie, C. Giannattasio, D. Hayoz, B. Pannier, C. Vlachopoulos, I. Wilkinson, H. Struijker-Boudier, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications Eur. Heart J., November 1, 2006; 27(21): 2588 - 2605. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Safar and A. Fournier Letter by Safar and Fournier Regarding Article, "Differential Impact of Blood Pressure-Lowering Drugs on Central Aortic Pressure and Clinical Outcomes: Principal Results of the Conduit Artery Function Evaluation (CAFE) Study" Circulation, October 10, 2006; 114(15): e539 - e539. [Full Text] [PDF]
|
|
|
|
 |
|
 N Bjarnegard, C Bengtsson, J Brodszki, G Sturfelt, O Nived, and T Lanne Increased aortic pulse wave velocity in middle aged women with systemic lupus erythematosus Lupus, October 1, 2006; 15(10): 644 - 650. [Abstract] [PDF]
|
|
|
|
|
|
G. F. Mitchell, Y. Lacourciere, J. M. O. Arnold, M. E. Dunlap, P. R. Conlin, and J. L. Izzo Jr Changes in Aortic Stiffness and Augmentation Index After Acute Converting Enzyme or Vasopeptidase Inhibition Hypertension, November 1, 2005; 46(5): 1111 - 1117. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. N. Vemmos, G. Tsivgoulis, and K. Spengos Association Between Pulse Pressure Values During the Acute Stroke Stage and Stroke Outcome Stroke, November 1, 2004; 35(11): 2436 - 2436. [Full Text] [PDF]
|
|
|
|
|
|
A. Mahmud and J. Feely Review: Arterial stiffness and the renin-angiotensin-aldosterone system Journal of Renin-Angiotensin-Aldosterone System, September 1, 2004; 5(3): 102 - 108. [Abstract] [PDF]
|
|
|
|
|
|
C. M. McEniery, M. Schmitt, A. Qasem, D. J. Webb, A. P. Avolio, I. B. Wilkinson, and J. R. Cockcroft Nebivolol Increases Arterial Distensibility In Vivo Hypertension, September 1, 2004; 44(3): 305 - 310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Weber, J. Auer, M. F. O'Rourke, E. Kvas, E. Lassnig, R. Berent, and B. Eber Arterial Stiffness, Wave Reflections, and the Risk of Coronary Artery Disease Circulation, January 20, 2004; 109(2): 184 - 189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. London, R. G. Asmar, M. F. O'Rourke, M. E. Safar, and REASON Project Investigators Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/Indapamide in hypertensive subjects: comparison with atenolol J. Am. Coll. Cardiol., January 7, 2004; 43(1): 92 - 99. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. S. Klassen, E. G. Lowrie, D. N. Reddan, E. R. DeLong, J. A. Coladonato, L. A. Szczech, J. M. Lazarus, and W. F. Owen Jr Association Between Pulse Pressure and Mortality in Patients Undergoing Maintenance Hemodialysis JAMA, March 27, 2002; 287(12): 1548 - 1555. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Westerbacka, A. Seppala-Lindroos, and H. Yki-Jarvinen Resistance to Acute Insulin Induced Decreases in Large Artery Stiffness Accompanies the Insulin Resistance Syndrome J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5262 - 5268. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Et-taouil, P. Schiavi, B. I. Levy, and G. E. Plante Sodium Intake, Large Artery Stiffness, and Proteoglycans in the Spontaneously Hypertensive Rat Hypertension, November 1, 2001; 38(5): 1172 - 1176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M.A.B. Van Bortel, H. A.J. Struijker-Boudier, and M. E. Safar Pulse Pressure, Arterial Stiffness, and Drug Treatment of Hypertension Hypertension, October 1, 2001; 38(4): 914 - 921. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Dart and B. A. Kingwell Pulse pressure--a review of mechanisms and clinical relevance J. Am. Coll. Cardiol., March 15, 2001; 37(4): 975 - 984. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Domanski, B. R. Davis, M. A. Pfeffer, M. Kastantin, and G. F. Mitchell Isolated Systolic Hypertension : Prognostic Information Provided by Pulse Pressure Hypertension, September 1, 1999; 34(3): 375 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Domanski, G. F. Mitchell, J. E. Norman, D. V. Exner, B. Pitt, and M. A. Pfeffer Independent prognostic information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction J. Am. Coll. Cardiol., March 15, 1999; 33(4): 951 - 958. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. F. Mitchell, L. A. Moye, E. Braunwald, J.-L. Rouleau, V. Bernstein, E. M. Geltman, G. C. Flaker, M. A. Pfeffer, and f. t. S. Investigators Sphygmomanometrically Determined Pulse Pressure Is a Powerful Independent Predictor of Recurrent Events After Myocardial Infarction in Patients With Impaired Left Ventricular Function Circulation, December 16, 1997; 96(12): 4254 - 4260. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. F. Mitchell, M. A. Pfeffer, P. V. Finn, and J. M. Pfeffer Comparison of techniques for measuring pulse-wave velocity in the rat J Appl Physiol, January 1, 1997; 82(1): 203 - 210. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||